Pillstats
Rx only · Tablet, Delayed Release · Oral

Erythromycin

Brands: Ery-Tab · Erythromycin

5 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US14 NDCs
5 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCD10AF02
RxCUI (US)4053
US makers5 labelers
Packages29
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 14 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.856$1.71$2.57$3.42Dec 2025Apr 2026Jul 2026
$2.927
Latest avg · Jul 22, 2026
-2%
Since Dec 17, 2025
5
Active US suppliers
52%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

7211.4K2.2K2.9K2025 Q12025 Q22025 Q32025 Q42026 Q1
2.4K
Rx · 2026 Q1
136K
Units dispensed
+8%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it5 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Torrent Pharmaceuticals Limitedunknown9SUPPLYING
Wilshire Pharmaceuticals, Inc.unknown6SUPPLYING
Amneal Pharmaceuticals LLCunknown6SUPPLYING
Arbor Pharmaceuticals, Inc.unknown6SUPPLYING
Golden State Medical Supply, Inc.unknown2SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.